Combined treatment of curcumin and small molecule inhibitors suppresses proliferation of A549 and H1299 human non-small-cell lung cancer cells. [electronic resource]
Producer: 20120612Description: 122-6 p. digitalISSN:- 1099-1573
- Antineoplastic Agents -- pharmacology
- Biological Availability
- Caffeic Acids -- pharmacology
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Chromones -- pharmacology
- Curcuma -- chemistry
- Curcumin -- pharmacology
- Drug Therapy, Combination
- Enzyme Inhibitors -- pharmacology
- ErbB Receptors -- antagonists & inhibitors
- Humans
- Morpholines -- pharmacology
- NF-kappa B -- antagonists & inhibitors
- Phenylethyl Alcohol -- analogs & derivatives
- Phosphoinositide-3 Kinase Inhibitors
- Phytotherapy
- Plant Extracts -- pharmacology
- Pyrimidines -- pharmacology
- Quinazolines -- pharmacology
- Receptors, Fibroblast Growth Factor -- antagonists & inhibitors
- Signal Transduction -- drug effects
- Somatomedins -- antagonists & inhibitors
- Tyrphostins -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.